HOME >> BIOLOGY >> NEWS
New guide helps researchers mine genome data

BETHESDA, Md., October 15, 2002 -- The Internet is teeming with user's guides for everything from cell phones to the space station. Now, to encourage greater scientific exploration of public databases containing the human genome sequence, the National Human Genome Research Institute (NHGRI) has created "A User's Guide to the Human Genome."

Published as a supplement to Nature Genetics and freely available at http://www.nature.com/ng/web_specials/, the peer-reviewed, how-to manual is aimed at spreading the word about how easy it is for researchers to mine the wealth of human genomic data that is freely available online.

"There is no point amassing all of this data in data warehouses if no one is able to use it," said Andreas D. Baxevanis, Ph.D., associate director of NHGRI's Division of Intramural Research (DIR) and co-author of the guide. "There is a barrier that people perceive about their ability to access genomic data and effectively use the data."

NHGRI Director Francis S. Collins, M.D., Ph.D., who was one of the guide's co-authors, added, "The average researcher in a biological or medical lab is somewhat overwhelmed by the avalanche of new freely-available data produced by the Human Genome Project. They know it's incredibly useful, but they're not quite sure how to use it. This guide was designed to overcome that barrier, and give 'power to the people.'"

In addition to Drs. Collins and Baxevanis, the guide was co-authored by Tyra G. Wolfsberg, Ph.D., associate director of NHGRI's Bioinformatics and Scientific Programming Core, Mark Guyer, Ph.D., director of the NHGRI Division of Extramural Research (DER), and Kris Wetterstrand, M.S., a program analyst for DER.

To further underscore the need for the user's guide, Dr. Baxevanis pointed to a Wellcome Trust's survey of nearly 800 biomedical scientists in 2001. The survey found that only half of the researchers who were alr
'"/>

Contact: Geoff Spencer
301-402-0911
NIH/National Human Genome Research Institute
15-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Diabodies act as guided missiles targeted to mammary tumor growth
2. Illustrated guidebook published for Chinese biomedical scientists and students
3. Nerve cells guided to repair spinal damage: Technique
4. New pulmonary hypertension guideline challenges use of common medication
5. New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients
6. New orchid bee guide
7. International critical care doctors release first-ever guidelines for sepsis
8. Shark guide probes uncharted waters
9. Revised guidelines published for testing for hereditary type of colorectal cancer
10. Traditional Inuit ice treks guided from space
11. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New guide helps researchers mine genome data

(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 ... of Debiopharm Group ™ , a Swiss-based global ... unmet medical needs as well as companion ... the investigational compounds Debio 1143 (SMAC mimetic) and ... at the 2015 Annual meeting of the ...
(Date:4/16/2015)... Washington (PRWEB) April 16, 2015 ... Applied Cancer Science and Resolution Bioscience, Inc. today ... to co-develop a novel, blood-based, clinic ready, Next ... cancer (NSCLC). The collaboration is the first to ... RET, and ROS1 fusions in blinded plasma samples ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
Cached News: